Lozano Martínez, A J <br/><br/>
Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Dec 2017 
 - 1531-1536 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-017-1699-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abiraterone Acetate--therapeutic use<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Blood Platelets--pathology<br/>Follow-Up Studies<br/>Humans<br/>Lymphocytes--pathology<br/>Male<br/>Middle Aged<br/>Neutrophils--pathology<br/>Prognosis<br/>Prostatic Neoplasms, Castration-Resistant--blood<br/>Retrospective Studies<br/>Survival Rate